Effectiveness of Physiotherapist's Communication Skills on Clinical Outcomes in Chronic Musculoskeletal Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Thessaly

About this trial

The purpose of this study is to investigate the impact of the physiotherapist's communication on the clinical presentation of patients with chronic musculoskeletal pain.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants should speak and understand the Greek language, as the questionnaires and the video will be in Greek

Participants should experience pain in one of the following four different areas: cervical or lumbar spine, knee, or shoulder

Pain of musculoskeletal origin

Pain lasting more than 3 months, evident on most days of the week to be classified as chronic pain, with a pain intensity of at least 3/10 Numeric Pain Rating Scale.

Disqualifiers

Medication for neurological/psychiatric disorders

Pain medication on the day agreed upon with the researcher, in order to minimize the potential influence of medication

Undergoing surgery in the last six months

Pregnancy or childbirth before 1 year

Trial design

Design model

Parallel

Treatments tested in this trial

  • Video about pain neuroscience education with enhancing communication skills

    Other intervention

    Participants will watch a brief video on pain neuroscience in which physiotherapist will show evidence-based communication skills to effectively convey information to patients.

  • Video about pain neuroscience education without enhancing communication skills

    Other intervention

    Participants will watch a brief video on pain neuroscience in which physiotherapist will not show evidence-based communication skills to effectively convey information to patients.

Treatment groups

69 Participants
are divided into 3 treatment groups
Group A: Good communication skillsExperimental treatment 1 intervention
Group B: Poor communication skillsExperimental treatment 1 intervention
Group C: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

NPRS: Numeric Pain Rating Scale

The Numeric Pain Rating Scale will be utilized to evaluate the severity of pain. Participants will provide a score ranging from 0 (indicating no pain) to 10 (representing the most intense pain they have ever felt).

Time frame
Changes from baseline to10 minutes after watching the video
2

PPT: Pressure Pain Threshold

The Pain Pressure Threshold (PPT) is a method utilized to quantify the sensitivity of deep muscular tissues. In this measurement, an algometer is commonly employed to apply pressure to a specific area, and the point at which a gradually increasing pressure becomes painful is noted. In the context of PPT, lower values are indicative of heightened sensitivity, suggesting that the individual experiences pain at a lower pressure threshold. Therefore, lower PPT values are interpreted as an indication of increased sensitivity in the deep muscular tissues.

Time frame
Changes from baseline to10 minutes after watching the video

Secondary outcomes

1

Pain Distribution

The Pain Distribution App (PDA) will be employed to document the location of pain. This self-reported tool is designed to evaluate the distribution and extent of pain across different areas of the body. The reliability of the PDA has been previously demonstrated.

Time frame
Changes from baseline to10 minutes after watching the video
2

CSI: Central Sensitisation Inventory

The Central Sensitisation Inventory (CSI) serves as a self-report tool aimed at identifying individuals with symptoms potentially linked to Central Sensitisation. The inventory consists of two parts. Part A involves 25 questions related to common Central Sensitisation Syndrome (CSS) symptoms. Patients rate each question on a scale from 0 (never) to 4 (always). A total score exceeding 40 suggests the presence of central sensitisation. In Part B, patients indicate if they have received a diagnosis for specific CSS disorders or related conditions, such as anxiety and depression. Notably, only the scores from Part A are considered in the assessment.

Time frame
Baseline
3

BIPQ: Brief Illness Perception Questionnaire

The Brief Illness Perception Questionnaire (B-IPQ) functions as an assessment tool for examining cognitive and emotional perceptions of illness. Comprising eight items, this questionnaire evaluates cognitive illness representation, emotional illness representation, and illness comprehensibility representation. Scoring involves rating each item on a scale from 0 to 10, where higher scores signify a more threatening perception of the illness. The total B-IPQ score is obtained by summing the scores of all eight items, resulting in a potential range of 0 to 80. Elevated scores on this scale indicate a more negative or distressing perception of the illness.

Time frame
Changes from baseline to 10 minutes after watching the video
4

PCS: Pain Catastrophizing Scale

The 13-item scale is structured around three dimensions: rumination over pain, magnification of pain, and helplessness in the face of pain symptoms. Both the total score and subscale scores for the Pain Catastrophizing Scale (PCS) are calculated by adding up the ratings for each item. In this study, the focus is on the total score, which ranges from 0 to 52, with higher scores indicating a higher level of pain catastrophizing.

Time frame
Changes from baseline to 10 minutes after watching the video

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.